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Abstract Fulminant Epstein–Barr virus (EBV+) T-cell
lymphoma in immunocompetent elderly patients is rare
and its character has not been well defined. This study
analyzed the clinicopathological features of five elderly
patients (group A: 50–84 years) and compared them with
those of eight children and young adult patients with
systemic T-cell lymphomas (group B: 10–34 years). Group
A more commonly presented with generalized lymphade-
nopathy (n=3) than did group B (n=1). Chronic active
EBV infection (n=3) and hydroa vacciniforme-like erup-
tions (n=1) were seen in group B, while group A showed
no evidence of chronic EBV infection, but did show
chronic hepatitis B or C virus infections (n=3). The
histological and immunophenotypical findings were similar.
All patients died within 1 to 14 months of diagnosis. These
findings suggest that EBV+ T-cell lymphoma in elderly
patients is a unique disease with an underlying derangement
of T-cell immunity and failure to eradicate infected virus.
Additional factors related to senility may play a role in the
disruption of homeostasis between the virus and the host’s
immune system.
Keywords Epstein–Barrvirus.Lymphoma.T-cell
Introduction
Primary infection with Epstein–Barr virus (EBV) is usually
asymptomatic,andEBVhasbeenshowntobelatentinBcells
for life innormalhosts after primaryinfection;however, some
children and more often, adolescents and young adults,
develop infectious mononucleosis (IM) [26]. IM is charac-
terized by fever, hepatosplenomegaly, lymphadenopathy, and
an increase in activated CD8+ T lymphocytes in the
peripheral blood [1, 26]. Although IM usually follows a
self-limited course without severe complications, uncom-
monly, acute EBV infections with fulminant manifestations
such as persistent fever, severe hepatosplenomegaly, severe
cytopenia, coagulopathy, central nervous system abnormal-
ities, and vascular dysfunction have been demonstrated, and
histiocytic erythrophagocytosis has been found in the bone
marrow and secondary lymphoid organs of most of these
patients [15, 28]. Those fulminant cases have been reported
mainly in Asian countries, including Taiwan and Japan, and
have been described under a variety of terms including
fulminant EBV+ T-cell lymphoproliferative disease(LPD) of
childhood, and sporadic fatal infectious mononucleosis.
These diseases occur shortly after primary EBV infection
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e-mail: yhko310@skku.eduor are associated with a long prodromal syndrome referred to
as chronic active EBV (CAEBV) infection.
CAEBV infection is characterized by chronic or recur-
rent infectious mononucleosis-like symptoms persisting for
at least 6 months and by an unusual pattern of anti-EBV
antibodies [24]. Severe CAEBV infection is a more severe
form of the disease, with a high mortality and high
morbidity and life-threatening complications such as vi-
rus-associated hemophagocytic syndrome, interstitial pneu-
monia, lymphoma, coronary aneurysms, and central
nervous system involvement [10, 16, 21, 22, 25]. Many
studies have reported that clonal expansion of EBV-infected
T or natural killer (NK) cells might be associated with
CAEBV infection [7, 8, 10, 11, 14, 16, 17, 23, 31].
A new World Health Organization classification for
fulminant EBV+ T-cell lymphoproliferative disorders,
which will appear in 2008, establishes a new disease
category of systemic EBV+ T-cell lymphoma. The disease
is defined as a life-threatening illness of children and young
adults characterized by a clonal proliferation of EBV-
infected T cells with an activated cytotoxic phenotype.
Whereas systemic EBV+ T-cell lymphomas most com-
monly occur in children and young adults, the similar entity
of fulminant EBV+ T-cell lymphoma can occur in immu-
nocompetent adult patients. In our institution, we have
noted several cases of fulminant EBV+ systemic T-cell
lymphomas in elderly patients with no known immunode-
ficiency. Those cases have clinicopathological features
similar to those of the systemic T-cell lymphoma of
children and young adults, but some differences were also
observed. Herein, we describe the clinicopathological
features and molecular and immunohistochemical findings
of 14 cases of fulminant EBV+ T-cell lymphoma to define
the characteristics of systemic EBV+ T-cell lymphoma in
elderly patients and to elucidate the relationship of these
tumors to those in children and young adult patients.
Materials and methods
Patients
The criteria for the inclusion of case were as follows: (1) an
aggressive clinical presentation with or without hemopha-
gocytic syndrome; (2) EBER positivity in a majority of
infiltrated lymphocytes; (3) clonal T-cell proliferation, as
supported by either T-cell receptor gene rearrangement
studies, or marked cytological atypia of CD3-positive cells;
and (4) available paraffin block(s) for additional studies.
This study was approved by the Institutional Review Board
in accordance with the Declaration of Helsinki.
The surgical pathology files of the Department of
Pathology, Samsung Medical Center from 1995 to 2007 were
searched. Of the 20 cases that showed EBV+ T-cell
lymphoproliferation, 13 cases were selected. Of the seven
cases excluded, the clinical history was unavailable for two,
one case had a history of rheumatoid arthritis, two cases were
of indolent cutaneous lymphoproliferative disorders, one case
was a typical hemophagocytic lymphohistiocytosis (HLH)
according to the definition of Henter et al. [6], and one case
showed polyclonal T-cell receptor gene rearrangements.
All patients were previously healthy, with no opportu-
nistic infections or other indications of congenital immu-
nodeficiency, nor had they received immunosuppressive
medications. We segregated our 13 cases into two groups:
elderly patients more than 50 years old, and children and
young adults.
Formalin-fixed, paraffin-embedded tissue blocks of liver,
bone marrow, lymph node, pharynx, tonsil, larynx, stom-
ach, duodenum, colon, retroperitoneum, and skin biopsies
were used for evaluation. All slides were reviewed by two
pathologists.
Immunophenotype studies
Immunohistochemical analysis was performed on paraffin
sections using monoclonal and polyclonal antibodies for the
detection of lineage-specific or lineage characteristic anti-
gens including CD3 (Dakopatts, Copenhagen, Denmark),
CD20 (Dakopatts), CD56 (Monosan, Uden, The Nether-
lands), CD4 (Novocastra, Newcastle upon Tyne, UK), CD8
(Novocastra), βF1 (Endogen, Rockford, IL, USA), and
granzyme B (Zymed, South San Francisco, CA, USA).
EBV studies
Serological studies of EBV infection were performed,
including the detection of antiviral capsid antigen IgG and
IgM (EBV-VCA IgG and IgM) and antiearly antigen IgG
(EBV-EA IgG) using indirect immunofluorescence meth-
ods, and antinuclear antigen (EBNA) using an anticomple-
ment immunofluorescence method.
EBV RNA was detected by an in situ hybridization
technique. Paraffin-embedded sections (5 μm) were dew-
axed with xylene, followed by treatment with proteinase K,
and hybridized with FITC-conjugated EBER-1 and EBER-2
oligonucleotide probes (Novocastra). Following incubation
with anti-FITC antibody tagged with alkaline phosphatase,
slides were covered with nitrobluetetrazolium, 5-bromo-4-
chloro-3-indolyl phosphate, and 1 M levamisole. We used
EBV-negative lymphoid tissues and the hybridization mix-
ture without EBVoligonucleotides as negative controls.
Real-time quantitative polymerase chain reaction (PCR)
assays for EBV DNA were performed using instruments
from Roche Molecular Diagnostics (Mannheim, Germany)
and the LightCycler EBV quantification kit as described
156 Virchows Arch (2008) 453:155–163[5]. The amount of EBV DNA was calculated as the
number of virus copies per 5 μl whole blood. The EBV
detection limit of this assay is approximately ten copies per
reaction for whole blood and the linear measuring range of
the assay is 10
2 to 10
6 per reaction.
Molecular studies
For PCR amplification of the TCR-γ locus, DNA was
prepared by standard proteinase K digestion and phenol/
chloroform extraction. PCR followed by single-stranded
conformational polymorphism analysis was performed as
previously described [18].
Detection of chromosomal abnormalities
Unstimulated isolated bone marrow cells were cultured for
24 h and G-banded according to standard procedures.
Metaphases were analyzed and karyotyped according to the
nomenclature system proposed by the International System
for Human Cytogenetic Nomenclature, 1995.
Results
Clinical findings
The clinical characteristics of the patients are summarized
in Tables 1 and 2. All patients were Korean, with eight male
and five female patients, ranging in age from 10 to 84 years
(mean 35.4 years). The elderly group consisted of five
patients (four males and one female), ranging from 50 to
84 years (mean 62 years), and the children and young adult
group consisted of eight patients (four males and four
females), ranging in age from 10 to 34 years (mean
16.7 years).
The clinical presentations of the children and young
adult group and the elderly group were similar, but with
some differences. In the elderly patients, three of the five
patients presented with generalized lymphadenopathy as
well as fever, cytopenia, and liver dysfunction (cases 1, 2,
and 5). One patient had fever, liver dysfunction, pancyto-
penia, and gastrointestinal symptoms (case 3). Biopsies
from the duodenum and colon revealed atypical cells. One
patient presented with abdominal pain and a retroperitoneal
mass (case 4). Anemia and thrombocytopenia were ob-
served in all patients. Bone marrow biopsy revealed
hemophagocytosis in one patient (case 3). A history of
hypersensitivity to mosquito bite or CAEBV infection was
not observed.
Among the children and young adults, four of eight
patients presented with acute onset of fever, general
malaise, and hepatosplenomegaly (cases 7–9a n d1 1 ) .
Laboratory testing showed pancytopenia and liver function
abnormalities. Among the other four patients, three had a
history compatible with chronic EBV infection. One of
them had a history of liver dysfunction and enlarged
cervical lymph nodes for 2 years (case 6). Other two
patients had intermittent fever of unknown origin for
6 months and 1 year respectively (cases 12 and 13). One
patient presented with hydroa vacciniforme-like skin
lesions on the light-exposed areas such as the face and
arms occurring over several years, along with IgA
nephropathy (case 10). At admission, the larynx was
involved by EBV+ T-cell lymphoma. Generalized lymph-
adenopathy was identified in only one case (case 6). Bone
marrow was initially infiltrated by hemophagocytic histio-
cytes or atypical tumor cells in the majority of cases.
All patients were treated with steroids or chemotherapy,
with various regimens depending on the patient’s general
condition; however, the clinical course was fulminant or
aggressive, with all patients dying within 10 days to
14 months of diagnosis. Causes of death for the elderly
patients were septic shock (four patients) and systemic
mucormycosis (one patient). The children and young adults
died of sepsis with disseminated intravascular coagulation
(two patients), pneumocystis pneumonia with disseminated
intravascular coagulation (one patient), multi-organ failure
(one patients), liver failure and tumor lysis syndrome (one
patient), and renal failure(one patient). Cause of death was
not known in one children.
Histological findings
Four out of five patients with lymphadenopathy had lymph
node biopsies. The lymph nodes in three patients (cases 1,
2, and 5) showed diffuse effacement of the normal nodal
architecture by infiltration of relatively monotonous small,
medium, or large lymphocytes with hyperchromatic nuclei
and irregular nuclear contours. Inflammatory cells such as
eosinophils and plasma cells were frequently found. The
lymph nodes from case 6 showed preserved but partially
effaced lymph node architecture and intact capsules and
sinuses. The interfollicular T zone was widened and
infiltrated by small lymphocytes lacking significant cyto-
logical atypia. Some of the lymphocytes were large.
Epithelioid histiocytes or small granulomas were scattered.
The bone marrow was involved in three patients. Tumor
cells massively infiltrated the bone marrow in case 11,
whereas case 7 and case 9 showed scattered pleomorphic
atypical cells with or without hemophagocytosis. Five
patients showed an infiltration of hemophagocytic histio-
cytes and increased small T lymphocytes without cytolog-
ical atypia.
Skin biopsies were performed in three cases (cases 1, 3,
and 10). Erythematous papules with or without ulceration
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158 Virchows Arch (2008) 453:155–163were documented clinically and showed perivascular and
periappendageal lymphocytic infiltration in the upper
dermis, with or without necrosis. One case showed a
subcutaneous infiltration of lymphocytes (case 3). The
patient with the hydroa vacciniforme-like eruption (case 10)
showed characteristic skin lesions. A biopsy of necrotic
vesicles demonstrated necrosis of the epidermis and
subjacent dermis. Perivascular and periappendageal lym-
phocytic infiltration of small lymphocytes with angioinva-
sion and mild atypia was observed.
Endoscopic biopsies from the stomach, duodenum, and
colon were performed for suspicious lesions from elderly
patients (cases 2 and 3). One patient showed mucosal
erosion with many T cells showing mild atypia and villous
atrophy (case 3) and no obvious atypical infiltrates were
observed in the other patient.
To compare the degree of histological change between
the elderly group and the children and young adult group,
we classified the 13 cases into three grades according to
histology (Figs. 1, 2 and 3). We defined grade 1 as cases
with polymorphic infiltrates including plasma cells, histio-
cytes, and small lymphocytes without significant atypia;
grade 2 as cases with monomorphic infiltrates with
predominantly small to medium lymphocytes showing mild
atypia; grade 3 as cases with overt lymphoma showing
monomorphic infiltrates with medium to large lymphocytes
showing marked atypia. The cytological atypia of grade 1
cases was minimal or equivocal, so if EBER in situ
hybridization is not performed, the lesion can be easily
overlooked as chronic inflammation. The elderly group and
the children and young adult group showed no significant
difference in the histological changes. The elderly group
showed one grade 1, two grade 2, and two grade 3 cases,
and the children and young adult group showed two grade
1, four grade 2, and two grade 3 cases.
Immunophenotypic findings
Immunophenotypic features are summarized in Table 1.
The infiltrate in all cases was composed of CD3+ T cells.
The CD4/8 phenotype was evaluated in four cases from the
elderly group and six cases from the children and young
Table 2 Comparison of clinical features between five elderly patients and eight children and young adult patients at presentation
Symptoms and signs Elderly patient Percent Children and young adults Percent
Fever 3/5 60 8/8 100
Anemia 5/5 100 7/8 87.5
Thrombocytopenia 5/5 100 7/8 87.5
Pancytopenia 4/5 80 6/8 75
Liver dysfunction 4/5 80 5/8 62.5
Hepatosplenomegaly 2/5 40 7/8 87.5
Lymphadenopathy 3/5 60 2/8 25
Skin rash 0/5 0 1/8 12.5
G-I symptoms 2/5 40 2/8 25
Pleural effusion/ascites 4/5 80 3/8 37.5
Bone marrow involvement 0/5 0 3/8 37.5
Hemophagocytosis in bone marrow 1/5 20 4/8 50
Associated disease
Hepatitis B or C virus infection 3/5 60 0/8 0
Hydroa vacciniforme 0/5 0 1/8 12.5
Chronic active EBV infection 0/5 0 4/8 50
Fig. 1 Microscopic finding of grade 1. There are polymorphic
infiltrates of plasma cells, histiocytes, and small lymphocytes without
significant atypia (case 6)
Virchows Arch (2008) 453:155–163 159adults group. Nine cases were evaluated by immunohisto-
chemistry and one case by flow cytometry. The infiltrate
was predominantly cytotoxic CD8+ αβ T cells in eight
cases (3/4 in the elderly group and 5/6 in the children and
young adults group). CD4+ and CD8+ T cells were
admixed with slight CD4 predominance in one case (1/6
in the children and young adult group). One elderly patient
was regarded of γ/δ phenotype due to the lack of staining
with the βF1 antibody in the proper reactivity with internal
control. Three cases did not have specimens available for
CD4 and CD8 study. All cases were negative for CD56 and
positive for granzyme B.
EBV analysis
EBV serology was available in eight patients. The EBV-
related antibody of each patient was detected, as shown in
Table 1. In all the cases examined, EBV-VCA IgG was
positive in the absence of EBV-VCA IgM. EBV-EA was
positive in two of five cases in the children and young adult
patients, but was consistently negative in the elderly
patients.
In situ hybridization (EBER-1) showed the presence of
EBV-infected cells in the tissues. All cases showed
numerous EBER-1 positive cells (Fig. 4).
Peripheral blood was obtained from five patients and the
viral load was determined by quantitative real-time PCR. In
four patients, the viral loads were measured serially over
observation periods ranging from 5 to 9 months (mean,
6.5 months). The highest results were shown in Table 1.
Gene rearrangement study
Analysis by PCR of paraffin-embedded tissue was per-
formed in nine cases—four from the elderly patient group
and five from the children and young adult patient group—
and showed clonal rearrangements of TCR-γ genes in all
cases.
Fig. 3 Microscopic finding of grade 3. Overt lymphoma showing
monomorphic infiltrates of large lymphocytes with marked atypia
(case 11)
Fig. 4 EBER in situ hybridization showing numerous positive cells
(case 7)
Fig. 2 Microscopic finding of grade 2. Monotonous infiltrates with
predominantly small to medium lymphocytes showing mild atypia
(case 4)
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Cytogenetic studies were successfully performed using
isolated bone marrow cells from six patients (five children
and young adult cases and one elderly patient case). Only
two patients from the children and young adults group
showed chromosomal abnormalities. The karyotypes of
those cases were 46XY, inv(14)(q11.2q32)[7]/46,XY[13]
(case 7) and 47,Y,-X,+19,+mar[1]/47,idem,add(12)(p12)[2]
(case 9).
Discussion
EBV-positive systemic T-cell lymphoma has been clinically
recognized as EBV-associated hemophagocytic lymphohis-
tiocytosis or EBV-associated hemophagocytic syndrome,
severe CAEBV infection, and fatal IM. Even though this
disease entity is rare, there have been many sporadic reports
describing fulminant T-cell LPD following acute EBV
infection and CAEBV infection in Asian countries espe-
cially Japan and Taiwan [15, 28]. The patients were mainly
children or young adults, with cases occurring in elderly
patients hard to find in the literature.
In this study, we compared the clinicopathological
features and immunohistochemical and molecular findings
of five elderly patients and eight children or young adult
patients. Although the study has limitations because of the
small number of elderly patients, the data suggested some
differences in the clinicopathological features. The cases in
the children and young adult group usually presented with
chronic intermittent or acute onset of fever, general malaise,
and hepatosplenomegaly. The bone marrow or liver was the
initial site of involvement and generalized lymphadenopa-
thy was unusual. Laboratory tests showed pancytopenia and
liver function abnormalities. The elderly patients more
commonly presented with generalized lymphadenopathy.
Hemophagocytosis or the involvement of bone marrow by
tumor cells was not common at initial presentation.
Regarding the underlying disease, a hydroa vaccini-
forme-like skin lesion was seen in one patient and chronic
active EBV infection in three patients in the children and
young adults group. Therefore, about 50% of the systemic
T-cell lymphomas in the children and young adult group
seem to develop through a prodromal period of chronic
EBV infection. This incidence of preceding chronic EBV
infection is higher than those reported previously by
Quintanilla-Martinez et al. [23]. Our five elderly patients
had no history of either CAEBV infection or hydroa
vacciniforme-like eruptions. Instead, three of five patients
were hepatitis B virus carriers or had chronic hepatitis C
virus infection. Although the patients had no proven
immune defects, the common association with hepatitis
virus in these patients suggests an apparently ineffective
antiviral T-cell response.
It is intriguing that IgA nephropathy was present in the
girl with the hydroa vacciniforme-like skin lesions and
subsequent development of T-cell lymphoma. A previous
study demonstrated the EBV genome in seven of 12
patients with IgA nephropathy (58%) and suggested that
EBV contributes to glomerular mesangial injury [9].
The histological features of 13 cases showed broad
cytological appearances ranging from a reactive appearance
to overt lymphoma, and there were no significant differ-
ences between the children and the elderly patients. Grade 1
histology was identified in two cases that revealed mono-
clonality according to TCR gene rearrangement and
numerous EBV-positive cells by in situ hybridization. The
differential diagnosis between reactive change and lympho-
ma was difficult on morphologic grounds alone. EBER in
situ hybridization is essential to avoid misdiagnosis.
We analyzed EBV-related antibodies in eight patients. In
primary EBV infection in healthy hosts, IgM antibodies to
VCA rise first, followed by VCA IgG and EBV-EA. EBV
IgM and EBV-EA will eventually disappear, and lastly, an
antibody to EBNA arises at least 1 month after the onset of
symptoms [30]. EBV IgG and EBNA will remain for life.
In many people, detection of antibody to the early antigen
is a sign of active infection. In the absence of EBNA, EBV-
EA indicates primary infection. Considering this principle,
the serologic profiles of the members of the children and
young adult group were more compatible with primary and
active EBV infection while those of the elderly patients
were compatible with past infection. However, high viral
loads and acute onset of disease in cases 1 and 3 in the
elderly group indicate active EBV infection. A recent study
demonstrated low frequencies of EBV-specific CD8+ T
cells in patients with chronic active EBV infection [29].
Failure to produce an antibody against EBV in elderly
patients seems to be associated with underlying antiviral T-
cell dysfunction.
The immunophenotype of the proliferating cells in the
children and young adults group in our study were
predominantly CD8-positive cytotoxic αβ T cells. Only
one case developed from a CAEBV infection and consisted
of mixed CD4+ and CD8+ cells with a predominance of
CD4+ cells. The elderly group showed similar results, with
a case with a γδ T-cell phenotype. Sporadic reports of
fulminant EBV+ T-cell LPD showed a predominantly
CD8+ phenotype with a few mixed CD4 and CD8
phenotype cells [2–4, 13, 19, 20, 27, 32]. However, other
studies could not find any subset predominance in EBV-
infected cells. Quintanilla-Martinez et al. [23] reported six
cases of fulminant EBV-positive clonal T-cell LPD after
acute or chronic EBV infection. The cells in two cases were
CD4+, two CD8+, and two had admixed CD4+ and CD8+
Virchows Arch (2008) 453:155–163 161cells. All were CD56-negative. In a recent retrospective
study of 43 children and young adult patients with EBV-
associated T/NK-cell lymphoproliferative disorders (severe
chronic active EBV infection), eight cases were compatible
with fulminant or subacute EBV+ T-cell LPD following
CAEBV infection, one case with a CD8+ phenotype, two
with a CD4+ phenotype, three with an admixture of CD8+
and CD4+ cells, and two showed a CD4−/CD8− pheno-
type. Six cases had αβ T cells and two γδ T cells [16].
Kasahara et al. analyzed the frequency of EBV-infected
cells in circulating lymphocyte subpopulations from four
patients with acute EBV-HLH and four with CAEBV
infection [12], and they showed that EBV-infected cells in
the acute phase of EBV-HLH were mainly an activated
CD8+ T-cell population, whereas the EBV-infected pop-
ulations in CAEBV infection were heterogeneous, includ-
ing CD4, CD8, B, and NK cells.
In conclusion, fulminant EBV+ systemic T-cell lympho-
ma of elderly patients is a rare disease that shares similar
clinical and pathologic findings with those seen in children
and young adults, but which has some differences in
clinical features. Although those elderly patients showed
no obvious immune defect, a common association with
chronic hepatitis virus infection suggests an underlying
derangement of T-cell immunity and failure to eradicate
infected virus. In these patients, additional factors related to
senility may play a role in the disruption of homeostasis
between the virus and the host’s immune system, eventually
leading to neoplastic transformation of EBV-infected T
lymphocytes.
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